Skip to content

Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study

Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04640363
Enrollment
300
Registered
2020-11-23
Start date
2020-12-01
Completion date
2024-05-31
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC, Recurrence Tumor

Keywords

Thermal ablation, Elastography, Ultrasound, Recurrence, Predictive Cancer Model

Brief summary

Combined F index, A index,ATT index and spleen stiffness to predict tumor recurrence in different liver settings after thermal ablation of HCC.

Detailed description

Thermal ablation is one of the established method for HCC treatment. Postoperative recurrence of HCC is one of the major factors leading to poor prognosis of HCC patients. Most studies have shown that the risk factors of recurrence include tumor size, tumor number and intrahepatic spread, etc. Besides, the carcinogenic effects of inflammatory activity and fibrosis in liver background caused by chronic hepatitis also be related to the recurrence. In the study, combi-elastography imaging technology , not only the F index which is related to liver fibrosis stage can be obtained, but also the A index which is related to inflammation activity can be measured, this may provide a more valuable method for tumor recurrence of early prediction.

Interventions

None listed

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18 to 80 years of age, and gender not limited;Chronic hepatitis B patients;The lesions of liver have the histopathological diagnosis of HCC and within MiLan criteria;All lesions were performed thermal ablation surgery;Sign the informed consent.

Exclusion criteria

* Lesions that unrealized complete inactivation evaluation by the enhanced imaging;Merging other systems' serious illness that can't cooperate with elastic imaging checking(such as heart failure, renal failure, such as mental illness);After liver transplantation patients;Patients with pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
F indexbaselineF index is linked to the degree of liver fibrosis,and it can be available by ultrasound elastography checking.
A indexbaselineA index is linked to the degree of hepatitis,and it can be available by ultrasound elastography checking.
ATT indexbaselineATT index is linked to the degree of steatosis of liver,and it can be available by ultrasound elastography checking.
Spleen stiffnessbaselineSpleen stiffness can be available by ultrasound elastography checking.

Countries

China

Contacts

Primary ContactJie Yu, Doctor
yu-jie301@hotmail.com010-66937981

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026